Moderna : AACR INT Head & Neck Poster -April 08, 2024 at 04:52 pm EDT
CT141 mRNA-4157 Individualized Neoantigen Therapy +...
Source: marketscreener.com
📰 Amgen News
Page 85 - Amgen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amgen. Real-time updates on events, politics, business and more.
Biologics and Biosimilars Landscape: IP, Policy, and Market Developments | Fish & Richardson
In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price...
West Virginia United States Johns Hopkins University Robertm Califf Eli Lilly Emgality Genentech Actemra
Source: jdsupra.com
CytomX Therapeutics : 2023 Annual Report -April 08, 2024 at 04:04 pm EDT
2 0 2 3 A n n u a l R e p o r t Dear Fellow CytomX Stockholders, Our vision at CytomX is to transform the...
United States South San Francisco Seana Mccarthy Exchange Commission Bristol Myers Squibb Securities Exchange
Source: marketscreener.com
150 top places to work in healthcare
Beckers Healthcare is delighted to release its 2024 list of 150 top places to work in healthcare.
Source: beckershospitalreview.com
Amgen (NASDAQ:AMGN) Earns "Outperform" Rating from Royal Bank of Canada
Royal Bank of Canada reaffirmed their outperform rating on shares of Amgen (NASDAQ:AMGN – Free Report) in a research note published on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has a $329.00 price objective on the medical research company’s stock. Several other equities research analysts have also recently issued reports on AMGN. Morgan […]
Source: dailypolitical.com
2 Biotech Stocks to Buy Hand Over Fist in April
These drugmakers have made important moves over the past year.
Source: fool.com
The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Looking ahead, the future of the U.S. economy appears promising despite ongoing...
Source: businessinsider.com
First Merchants Corp Decreases Holdings in Amgen Inc. (NASDAQ:AMGN)
First Merchants Corp cut its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 13,007 shares of the medical research company’s stock after selling 251 shares during the period. First […]
Raymond James Providence Capital Advisors Briaud Financial Planning Inc First Merchants Corp Strategic Investment Solutions Inc Visionpoint Advisory Group
Source: dailypolitical.com
180 Wealth Advisors LLC Has $591,000 Position in Amgen Inc. (NASDAQ:AMGN)
180 Wealth Advisors LLC cut its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 4.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,988 shares of the medical research company’s stock after selling 87 shares during the period. 180 Wealth Advisors LLC’s […]
Raymond James Royal Bank Northern Trust Corp Moneta Group Investment Advisors Morgan Stanley Wealth Advisors
Source: dailypolitical.com
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Grimes & Company Inc.
Grimes & Company Inc. lifted its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 91,431 shares of the medical research company’s stock after acquiring an additional 647 […]
Raymond James Visionpoint Advisory Group Securities Exchange Commission Grimes Company Inc Goldman Sachs Group Strategic Investment Solutions Inc
Source: tickerreport.com